Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

116.93

-2.87 (-2.40%)

At close: Aug 27, 2026, 4:00 PM EDT

116.25

-0.68 (-0.58%)

After-hours: Aug 27, 2026, 4:05 PM EDT

Corcept Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	12,641	3,661	5,280	3,348	2,186	2,097
Market Cap Growth	74.32%	-30.67%	57.69%	53.13%	4.24%	-30.98%
Enterprise Value	12,106	3,143	4,739	2,933	1,787	1,603
Last Close Price	119.80	34.80	50.39	32.48	20.31	19.80

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	257.77	37.29	37.78	31.74	21.59	18.64
Forward PE	29.31	55.53	32.11	32.61	19.95	21.01
PS Ratio	15.36	4.81	7.82	6.94	5.44	5.73
PB Ratio	18.32	5.65	7.77	6.61	4.36	5.58
P/TBV Ratio	18.08	5.65	7.77	6.61	4.36	5.58
P/FCF Ratio	119.33	25.82	26.92	26.46	18.23	12.53
P/OCF Ratio	116.31	25.78	26.63	26.43	18.17	12.49
PEG Ratio	-	1.96	1.96	1.96	1.96	1.50

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	14.71	4.13	7.02	6.08	4.45	4.38
EV/EBITDA Ratio	1512.08	68.40	34.40	27.08	15.69	12.73
EV/EBIT Ratio	1908.45	70.15	34.60	27.34	15.87	12.88
EV/FCF Ratio	114.32	22.17	24.16	23.18	14.90	9.58

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.01	0.01	0	0.00	0.00
Debt / EBITDA Ratio	0.86	0.13	0.05	0.00	0.01	0.00
Debt / FCF Ratio	0.09	0.04	0.04	0.00	0.01	0.00
Net Debt / Equity Ratio	-0.76	-0.81	-0.88	-0.84	-0.87	-0.89
Net Debt / EBITDA Ratio	-66.21	-11.45	-4.33	-3.93	-3.82	-2.66
Net Debt / FCF Ratio	-5.01	-3.71	-3.04	-3.36	-3.63	-2.00
Asset Turnover	0.98	0.91	0.92	0.80	0.80	0.74
Inventory Turnover	1.11	1.03	1.08	0.94	0.97	1.07
Quick Ratio	2.50	2.60	3.11	4.05	6.60	5.31
Current Ratio	2.86	2.92	3.35	4.39	6.89	5.61
Return on Equity (ROE)	8.23%	15.02%	23.81%	21.05%	23.11%	25.03%
Return on Assets (ROA)	0.47%	3.34%	11.71%	11.13%	13.98%	15.63%
Return on Invested Capital (ROIC)	1.79%	15.32%	54.21%	87.09%	87.74%	94.15%
Return on Capital Employed (ROCE)	0.90%	6.70%	19.60%	20.80%	22.00%	33.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	0.43%	2.72%	2.67%	3.17%	4.64%	5.36%
FCF Yield	0.84%	3.87%	3.72%	3.78%	5.48%	7.98%
Buyback Yield / Dilution	0.22%	-5.73%	-1.55%	3.64%	7.94%	-1.42%

SEC Filings: 10-K · 10-Q